EMERYVILLE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full ...
If you'd rather avoid paying for another subscription, and are willing to learn a little bit of Markdown (essentially, a way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback